{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T07:20:30Z","timestamp":1793431230443,"version":"4.5.0"},"reference-count":94,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Acute lymphoblastic leukaemia (ALL) in 20%\u201330% of adult patients contains the Philadelphia (Ph+) chromosome. Historically, Ph+ ALL denoted a markedly inferior outcome and long\u2010term survival in the absence of an allograft was uncommon. However, the advent of targeted therapy directed against the\n                    <jats:italic>BCR::ABL1<\/jats:italic>\n                    fusion protein with various tyrosine kinase inhibitors (TKIs) has markedly improved the prognosis, resulting in a number of treatment controversies in allograft\u2010eligible patients. Which is the best TKI to use in induction? What is the clinical relevance of the subdivision of Ph+ ALL into multilineage vs lymphoid types? Do all patients in first morphological complete remission (CR1) after induction and consolidation with chemotherapy\/TKI require an allograft? If not, what risk factors predict a poor outcome without an allograft? Can chemotherapy\u2010free approaches, such as blinatumomab in conjunction with more potent TKIs, obviate the need for an allograft in high\u2010risk patients? What is the best strategy to deal with persistent or emerging minimal residual disease both pre\u2010 and post\u2010transplant? Is maintenance TKI indicated in all patients post allograft? Can salvage therapy and a subsequent allograft cure patients who relapse after not being transplanted in CR1? This manuscript reviews the latest data influencing contemporary management and discusses these controversies.\n                  <\/jats:p>","DOI":"10.1111\/bjh.19682","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T01:09:36Z","timestamp":1726621776000},"page":"39-53","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A critical review of management of allogeneic transplant\u2010eligible adults with Ph+ acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5895-8797","authenticated-orcid":false,"given":"Naranie","family":"Shanmuganathan","sequence":"first","affiliation":[{"name":"Department of Haematology Royal Adelaide Hospital and SA Pathology  Adelaide South Australia Australia"},{"name":"Precision Cancer Medicine Theme South Australian Health &amp; Medical Research Institute  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[{"name":"Department of Clinical Haematology Austin Hospital  Heidelberg Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2113347"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.080432"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.050"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016194"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01668-0"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021752"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature06866"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.196055"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.3617"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.5868"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-11-466482"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22206"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023502"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-052373"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-261586"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004813"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01075"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.260935"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28522"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306494"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(18)30176-5"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-167761"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30231"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.07.006"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007764"},{"key":"e_1_2_12_28_1","volume-title":"Ponatinib versus imatinib in patients with newly diagnosed Ph+ acute lymphoblastic leukemia in the phase 3 PhALLCON trial: in\u2010depth responder analysis","author":"Ribera J\u2010M","year":"2024"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-179537"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004821"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature21702"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-174246"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-529008"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-02-627935"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004607"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052746"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-05-351403"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2016272"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008216"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00272"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4666"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29646"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(03)01050-7"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2021.1894647"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26816"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-148791"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-022-00265-2"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-188188"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.03.021"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.06.006"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390010"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-707562"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2018.03.002"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-418-6_7"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0496-7"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.10023"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26949"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2021.05.010"},{"key":"e_1_2_12_59_1","first-page":"1144","article-title":"Variant BCR\u2010ABL1 fusion genes in adult Philadelphia chromosome\u2010positive B\u2010cell acute lymphoblastic leukemia","volume":"16","author":"Langabeer SE","year":"2017","journal-title":"EXCLI J"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13714"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.253"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.11.003"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001495"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000844300.04335.af"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27041"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277\u2010024\u201005682\u20103"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00320"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003536"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.352"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004685"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002945"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018027003"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16540"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.085811"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33529"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2008.03.031"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00967"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-796862"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00108"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-022-00766-7"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26634"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022330"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001499"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004916"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02529"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2010.314"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2022.106930"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023011514"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.014"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.05.026"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25648"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33321"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.12.022"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-187988"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00546"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19682","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.19682","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.19682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:19:37Z","timestamp":1771035577000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.19682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1111\/bjh.19682"],"URL":"https:\/\/doi.org\/10.1111\/bjh.19682","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"2024-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}